COMPASS Study: an Online Cognitive-behavioural Therapy (CBT) Program Treating Anxiety and Low Mood in Long-term Conditions During the COVID-19 Pandemic

Summary

This study is a single-centre, interventional randomised controlled trial.

Participants will be individually randomised to receive either COMPASS online CBT + "usual care" (standard LTC charity support), or usual care only. Randomisation will be stratified by recruiting charity site to ensure a balance of participants with different LTCs across the intervention and control arm. Randomisation will occur using a 1:1 allocation ratio managed by RECAP software.

Participants randomised to COMPASS will receive access to the online program. It consists of 11 online modules which target challenges associated with living with LTC(s) and includes, amongst other things, psycho-education, patient examples, interactive tasks and goal setting. Participants are linked to a therapist; 'guide', who will provide 6 x 30 minute support sessions delivered fortnightly in the format preferred by the client (phone and/or in-site message).

Participants allocated to the usual care control arm will receive the usual care that is available to them via their charity. All charities include a helpline which can be accessed via telephone or email. The helplines at all charities offer one-off emotional and/or informational support provided by people trained in active listening and/or counselling skills. Additional support avenues that can be accessed may include online support groups, local community support groups and informational resources.

Conditions

• Treatment of Illness-related Distress in Physical LTCs

Interventions

BEHAVIORAL

COMPASS

An 11 module, therapist-supported online CBT program.

BEHAVIORAL

Standard charity resources

Resources provided by the charities involved, including supportive listening, online support groups, information resources and local community support groups.

Sponsors & Collaborators

• National Multiple Sclerosis Society

  collaborator OTHER

• Psoriasis Association

  collaborator UNKNOWN

• Crohn's & Colitis UK

  collaborator UNKNOWN

• Kidney Care UK

  collaborator OTHER

• Shift.ms

  collaborator UNKNOWN

• King's College London

  lead OTHER

Principal Investigators

• Rona Moss-Morris · King's College London

Study Design

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

SINGLE

Model

PARALLEL

Eligibility

Min Age

18 Years

Sex

ALL

Healthy Volunteers

No

Timeline & Regulatory

Start

2020-11-16

Primary Completion

2021-07-01

Completion

2022-01-01

Countries

• United Kingdom

Study Locations